EMAIL US: customerservice@franklinyoung.com
CALL US: (618) 724-2780 / (909) 931-5012
CALL US: (618) 724-2780 / (909) 931-5012
Back to Previous Page
ITEM#: 3042-SCC210
MFR#: SCC210
Triple negative breast cancer (TNBC) accounts for 15-20% of breast cancer cases and is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human EGF receptor 2 (HER2) . TNBC is typically more aggressive and difficu
| Product Name | Description | Item# | QTY | |
|---|---|---|---|---|
PMC42-LA Human Breast Cancer Cell Line PMC42-LA human breast cancer cell line is a mammary epithelial cell model that can be used to study epithelial to mesenchymal transition.
|
PMC42-LA is a stable epithelial variant of the mesenchyme-like parental PMC42 /PMC42-ET cell line. PMC42-LA congregate into pavement epithelial sheets at high density, in which the cell-cell borders contain E-cadherin and -catenin, albeit 5-10% of ce | 3042-SCC139 | EA | |
MCF-7/S0.5 Human Breast Cancer Cell Line MCF-7/S0.5 is a tamoxifen-sensitive cell line established from the MCF-7 human breast cancer cell line by adaption to growth in low serum conditions.
|
Estrogen receptor-positive breast cancer is the most common type of breast cancer. About 80% of all breast cancers express the estrogen receptor (ER+) and depend on estrogen to support the growth and spread of the cancer cells. Hormonal therapy, such | 3042-SCC100 | EA | |
MCF-7/TAMR-1 Human Breast Cancer Cell Line MCF-7/TAMR-1 is a tamoxifen-resistant cell line derived from the MCF-7/S0.5 human breast cancer cell line by long term treatment with the drug tamoxifen.
|
Estrogen receptor-positive breast cancer is the most common type of breast cancer. About 80% of all breast cancers express the estrogen receptor (ER+) and depend on estrogen to support the growth and spread of the cancer cells. Hormonal therapy, such | 3042-SCC101 | EA | |
BOB CELL LINE HUMAN PROSTAT CANCER
|
Bob cell line human | 3042-100211021VL | EA | |
CR4 Human Colorectal Cancer Cell Line
|
Colorectal cancer (CRC) is the 2nd highest cause of cancer death in the United States. Increasing evidence suggests that a small population of cancer-initiating cells (CICs) or cancer stem cells (CSCs) are responsible for tumorigenesis and the except | 3042-SCC107 | EA |